Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IFS
IFS logo

IFS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Intercorp Financial Services Inc (IFS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
46.430
1 Day change
-0.56%
52 Week Range
52.580
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Intercorp Financial Services Inc (IFS) is not a strong buy at the moment for a long-term beginner investor. While the company shows strong financial growth in the latest quarter, technical indicators and trading sentiment do not support a compelling entry point. Additionally, there are no significant catalysts or trading signals to suggest immediate action.

Technical Analysis

The MACD is negatively expanding (-0.703), RSI is neutral at 22.042, and moving averages are converging, indicating no clear trend. The stock is trading below its pivot level (47.951) with key support at 45.28 and resistance at 50.621.

Positive Catalysts

  • Strong financial performance in Q3 2025 with revenue up 5.01% YoY, net income up 16.87% YoY, and EPS up 410.32% YoY. JPMorgan raised the price target to $48 and maintained an Overweight rating.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from hedge funds, insiders, or Congress. Technical indicators show no bullish signals, and the stock is trading below its pivot level.

Financial Performance

In Q3 2025, revenue increased to $1.65 billion (up 5.01% YoY), net income rose to $453.31 million (up 16.87% YoY), and EPS surged to 17.3 (up 410.32% YoY). Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

JPMorgan raised the price target to $48 from $42 and maintained an Overweight rating, indicating a positive long-term outlook for the stock.

Wall Street analysts forecast IFS stock price to rise
1 Analyst Rating
Wall Street analysts forecast IFS stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 46.690
sliders
Low
48
Averages
48
High
48
Current: 46.690
sliders
Low
48
Averages
48
High
48
JPMorgan
NULL -> Overweight
upgrade
$42 -> $48
AI Analysis
2025-12-16
Reason
JPMorgan
Price Target
$42 -> $48
AI Analysis
2025-12-16
upgrade
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Intercorp Financial to $48 from $42 and keeps an Overweight rating on the shares.
BofA
Buy
maintain
$40 -> $43
2025-05-09
Reason
BofA
Price Target
$40 -> $43
2025-05-09
maintain
Buy
Reason
BofA raised the firm's price target on Intercorp Financial to $43 from $40 and keeps a Buy rating on the shares after Q1 results exceeded expectations and the insurance unit "took the spotlight." After a "strong" Q1 earnings beat, the firm believes the earnings recovery is on track, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IFS
Unlock Now

People Also Watch